Metoclopramide (injection)
متوکلوپرامید (آمپول)
🍽️ Alimentary Tract And MetabolismProkinetic antiemetic
Market / country: 🇺🇸 USA
Reglan injection (US)
🧮 Dose calculator
Nausea and vomiting · Regimen source: FDA Metoclopramide inj. · Dosage and Administration
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ History of tardive dyskinesia or dystonic reaction; GI haemorrhage, obstruction or perforation; pheochromocytoma; epilepsy. FDA Metoclopramide inj. · Contraindications
- ⚠️ Boxed warning: tardive dyskinesia; avoid use longer than 12 weeks. FDA Metoclopramide inj. · Boxed Warning
Formulations
- 10 mg/2 mL (5 mg/mL) — injection 🇺🇸 USA FDA Metoclopramide inj. · How Supplied
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Metoclopramide inj. · Pregnancy
“Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Metoclopramide inj. · Nursing Mothers
“Metoclopramide is excreted in human milk.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Metoclopramide inj. · Pediatric Use
“The safety and effectiveness of metoclopramide injection has been established as a single-dose to facilitate small bowel intubation in pediatric patients in whom the tube does not pass the pylorus with conventional maneuvers.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Metoclopramide inj. · Geriatric Use
“For these reasons, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased renal function, concomitant disease, or other drug therapy in the elderly (see DOSAGE AND ADMINISTRATION - Use in Patients with Renal or …”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA217072
- DailyMed (FDA label)FDA Metoclopramide inj.
- MedlinePlus (NIH)MetoclopramideMetoclopramide Injection
- WHO ATC/DDDA03FA01
- Darooyab (Iran)Metoclopramide
🇮🇷 Registered in Iran Darooyab · G-2614/Metoclopramide
Dosage forms with Iranian generic codes, per Darooyab.
- 18780 · METOCLOPRAMIDE 10MG SOFT GEL CAP · کپسول نرم متوکلوپرامید ۱۰ میلیگرم
- 00841 · METOCLOPRAMIDE 10MG TAB · قرص متوکلوپرامید ۱۰ میلیگرم
- 00839 · METOCLOPRAMIDE 10MG/2ML AMP · آمپول متوکلوپرامید ۱۰ میلیگرم / ۲ میلیلیتر
- 00840 · METOCLOPRAMIDE 4MG/ML 15ML ORAL DROP · قطره خوراکی متوکلوپرامید ۴ میلیگرم / میلیلیتر ۱۵ میلیلیتر
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Metoclopramide inj. · How SuppliedFDA Metoclopramide inj. · Dosage and AdministrationFDA Metoclopramide inj. · ContraindicationsFDA Metoclopramide inj. · Boxed WarningFDA Metoclopramide inj. · PregnancyFDA Metoclopramide inj. · Nursing MothersFDA Metoclopramide inj. · Pediatric UseFDA Metoclopramide inj. · Geriatric UseFDA Metoclopramide inj. · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-2614/Metoclopramide
- Clinical review⚠ Unverified